期刊文献+

壳聚糖在药物缓释中的研究进展 被引量:9

Progress of chitosan on sustained drug delivery
下载PDF
导出
出处 《海洋科学》 CAS CSCD 北大核心 2006年第3期85-89,共5页 Marine Sciences
基金 国家自然科学基金资助项目(30370344)
  • 相关文献

参考文献20

  • 1石玲,胡利平,浦锦宝,李端阳,孙秀珍,贾建东.壳聚糖的安全性研究[J].中国海洋药物,2000,19(1):25-28. 被引量:60
  • 2曾名勇.几种甲壳质衍生物在医药上的应用[J].中国海洋药物,1995,14(1):49-52. 被引量:22
  • 3Liu L S, Liu S Q, Ng S Y, et al. Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres[J]. Journal of Controlled Release, 1997,43(1 ):65 - 74.
  • 4Jameela S R, Kumary T V, Lal A V, et al. Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system[J]. Journal of Controlled Release, 1998,52(1-2):17 - 24.
  • 5Hejazi R, Amiji M. Stomach-specific anti-H pylori therapy I: preparation and characterization of tetracycline-loaded chitosan microspheres[J]. International Journal of Pharmaceuties, 2002, 235(1-2):87 - 94.
  • 6Mi F L, Shyu S S, Chen C T, et al. Porous chitosan microsphere for controlling the antigen release of Newcastle disease vaccine: preparation of antigen-absorbed microspheres and in vitro release[J]. Biomaterials, 1999,20(17): 1 603 - 1 612.
  • 7Ganza-GonzAlez A, Anguiano-lgea S, Otero-Espinar G J, et al.Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide[J].European Journal of Pharmaceutics and Biopharmaceutics, 1999,48(2):149- 155.
  • 8Alonso M J, Vila-Jato J L. Development of new chitosan-cellulose multicore microparticles for controlled drug delivery[J]. European Journal of Pharmaceuties and Biopharmaceutics, 1998,45:49 - 56.
  • 9Jameela S R, Jayakrishnan A. Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro releases of mitoxantrone and in vivo degradation of microspheres in rat muscle[J]. Biomaterials, 1995,16(10):769 - 775.
  • 10Conti B M, Genta I T. A proposed new method for the cross-linking of chitosan microsphere[J]. Drug Delivery,1998,5(2):87.

二级参考文献14

  • 1程宇慧,廖工铁,侯世祥,李栗,张明.白蛋白微球作为肝靶向给药载体的研究[J].药学学报,1993,28(1):68-74. 被引量:20
  • 2徐淑云,药理实验方法(第2版),1994年
  • 3陈奇,中药药理实验方法学(第2版),1994年,118页
  • 4徐淑云 卞如谦 陈修.药理实验方法[M].北京:人民卫生出版社,1994.968.
  • 5BoisdronCM,Menei P,Benoit JP. Preparation and Characterization of 5-fluorouracil-loadedmicroparticles as biodegradable anticancer drug carriers. J Pharm Pharmacol,1995,47(2):108.
  • 6Ciftci K,Hincal AA,Kas HS et al. Solid tumor chemotherapy and in vivo distributionof fluorouracil following administration in Poly (L-lactic acid)microspheres. Pharm DevTechnol,1997, 2(2):151.
  • 7Lisbeth I. Chitosan and its use as a pharmaceutical excipient. Pharm Res,1998,15(9):1326.
  • 8H Suheyl Kas. Chitosan:properties,preparations and application to microparticulatesystems. J Microencapsul,1997,14(6):689.
  • 9Sheu MT,Sokoloski TD. Entrapment of bioactive compounds within native albuminbeads:Ⅲ. Evaluation of parameters affecting drug release. J Parenter Sci Tec hnol,1986,40(6):259.
  • 10Nishimura.k. Nishimura ST et al:Effect of multiporous microspheres de vised fr omchitin and partially deacetylated chitin on the activation of mouse peritonea lmacrophages. Vaccine,1987,5:136.

共引文献99

同被引文献133

引证文献9

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部